¥ß¥È¥³¥¢¡¼ ÌȱÖÎÏ¥¢¥Ã¥×¤Î¥Þ¥ë¥Á¥Ó¥¿¥ß¥ó¡¦¥ß¥Í¥é¥ë

¥ß¥È¥³¥¢¡¼ ÌȱÖÎÏ¥¢¥Ã¥×¤Î¥Þ¥ë¥Á¥Ó¥¿¥ß¥ó¡¦¥ß¥Í¥é¥ë
·¿ÈÖOMPMT
ÈÎÇä²Á³Ê

8,154±ß

¹ØÆþ¿ô

MITOCORE/ Ortho Molecular Product
120¥«¥×¥»¥ë


¥ß¥È¥³¥¢¡¼¤Ï¤³¤ó¤Ê¿Í¤Ë¤ª¥¹¥¹¥á¤Ç¤¹¡£

  • ¥¨¥¤¥º
  • HIV´¶À÷¾É
  • ¥¬¥ó¤òȯ¾É¤·¤Æ¤¤¤ëÊý¤ÎÌȱ֥µ¥Ý¡¼¥È
  • ÌȱÖÎϤÎÄã²¼¤·¤Æ¤¤¤ëÊý

¥ß¥È¥³¥¢¡¼¤ÏÂΤÎÃæ¤Ç¤³¤ó¤ÊÉ÷¤ËƯ¤­¤Þ¤¹¡£

MITOCORE¤ÏºÙ˦Æâ¤Î¥¨¥Í¥ë¥®¡¼¤ò¹â¤á¤ë¤³¤È¤ÇÌȱÖÎϤò¥¢¥Ã¥×¤µ¤»¤ë¥µ¥×¥á¥ó¥È¤Ç¤¹¡£ÆâÍÆÀ®Ê¬¤Î
¥¢¥»¥Á¥ë¡¾L-¥«¥ë¥Ë¥Á¥ó¤ÏºÙ˦Æâ¤Ç¤Î¥¨¥Í¥ë¥®¡¼¤ÎÀ¸»º¤ò¹â¤á¤ë¤³¤È¤¬ÃΤé¤ì¤Æ¤¤¤Þ¤¹¡£¥¢¥»¥Á¥ë¡¾L-¥«¥ë¥Ë¥Á¥ó¤ÏÇò·ìµå¤Î¼«Á³»à¤ò¸º¾¯¤µ¤»¡¢Áý¿£¤ò²Ã®¤µ¤»¤Þ¤¹¡£
N¡Ý¥¢¥»¥Á¥ë¥·¥¹¥Æ¥¤¥ó¤Ï¥°¥ë¥¿¥Á¥ª¥ó¤Î¸¶ÎÁ¤È¤Ê¤ê¤Þ¤¹¡£
¥°¥ë¥¿¥Á¥ª¥ó¤ÏÌȱÖÎϤò¹â¤á¤ë¤À¤±¤Ç¤Ê¤¯¡¢¹³»À²½Êª¼Á¤È¤·¤Æ¤âÃΤé¤ìÂÎÆâ¤Î²òÆÇ¤Ë¤Ï·ç¤«¤»¤Ê¤¤Êª¼Á¤Ç¤¹¡£¥°¥ë¥¿¥Á¥ª¥ó¤¬¸º¾¯¤¹¤ë¤ÈT¥ê¥ó¥Ñµå¤Î³èư¤¬¸º¾¯¤·¤Þ¤¹¡£
¥ì¥¹¥Ù¥é¥È¥í¡¼¥ë¤Ë¤Ïȯ¤¬¤óÀ­Êª¼Á¤Î²òÆÇ¡¢¹³»À²½Êª¼Á¡¢¹³²ÃÎð¡¢ÌȱֳèÀ­Ç½ÎϤ¬¤¢¤ê¤Þ¤¹¡£
¥¹¥ë¥Õ¥©¥é¥Õ¥¡¥ó¤Ï¹³¥¬¥ó°äÅÁ»Ò¤ò³èÀ­²½¤µ¤»¡¢¥°¥ë¥¿¥Á¥ª¥ó¤ÎÀ¸»º¤ò¹â¤á¤Þ¤¹¡£
ÎÐÃãÃê½Ðʪ¤Ë¤Ï¹âÇ»Å١ʽãÅÙ45¡ó°Ê¾å¡Ë¤Î¥Ý¥ê¥Õ¥§¥Î¡¼¥ëEGCG¤¬´Þ¤Þ¤ì¤Þ¤¹¡£¥Ý¥ê¥Õ¥§¥Î¡¼¥ëEGCG¤Ï¶¯ÎϤʹ³»À²½Ç½ÎÏ¡¢Ä²Æâ¤ËÀ¸Â©¤¹¤ëÆý»À¶Ý¤ä¥Ó¥Õ¥£¥º¥¹¶Ý¤òÁý¤ä¤¹¡¢ÌȱÖÎϤò¹â¤á¤ëƯ¤­¤¬¤¢¤ê¤Þ¤¹¡£¤Þ¤¿´Î¡¤Î²òÆÇµ¡Ç½¤ò¹â¤á¤ë¤³¤È¤ÇÍ­³²¤Ê²½³ØÊª¼Á¤òÂγ°¤ËÇӽФ¹¤ë¤Î¤³¤È¤òÂ¥¿Ê¤·¤Þ¤¹¡£
¥Ó¥¿¥ß¥ó¡¢¥ß¥Í¥é¥ë MITOCORE¤Ë¤ÏºÙ˦Æâ¤Ç¤Î¥¨¥Í¥ë¥®¡¼À¸»ºÇ½ÎϤòºÇÂç¸Â°ú¤­½Ð¤¹¤è¤¦¤ËÄ´¹ç¤µ¤ì¤¿¥Ó¥¿¥ß¥ó¡¢¥ß¥Í¥é¥ë¤¬Ç۹礵¤ì¤Æ¤¤¤Þ¤¹¡£
¤Þ¤¿¤³¤Î¥µ¥×¥ê¥á¥ó¥È¤Ï¥¨¥¤¥º¥¦¥£¥ë¥¹¤Ë´¶À÷¤·¤Æ¤¤¤ë´µ¼Ô¤òÂоݤ˹Ԥä¿Æó½ÅÌÕµ¶Ìô¥³¥ó¥È¥í¡¼¥ë»î¸³¤Ë¤ª¤¤¤ÆCD4¤Î¿ôÃͤò12½µ´Ö¤Ç24¡ó¤â¾å¾º¤µ¤»¤Þ¤·¤¿¡£¡Ê¥¨¥¤¥º¤òȯ¾É¤¹¤ë¤ÈCD4ÌȱֺÙ˦¤Î¿ôÃͤ¬¸º¾¯¤·Æüϸ«´¶À÷¤ò·«¤êÊÖ¤¹¤è¤¦¤Ë¤Ê¤ê¤Þ¤¹¡£¡Ë

¥ª¥ë¥½¥â¥ì¥­¥å¥é¼Ò¤Î¥ß¥È¥³¥¢¡¼¤È¾¼Ò¤ÎÀ½ÉʤȤΰ㤤¤Ï²¿¤Ç¤¹¤«¡©

MITOCORE¤Ï¥¨¥¤¥º¤òȯ¾É¤·¤¿´¶À÷¼Ô¤ÎCD4¤Î¿ôÃͤò¾å¾º¤µ¤»¤ë¸ú²Ì¤¬¤¢¤ê¤Þ¤¹¡£¥Ë¥å¡¼¥è¡¼¥¯½£¤Ç¤Ï¥¨¥¤¥º´µ¼Ô¤Ø¤ÎÊݸ±Å¬ÍÑ(Medicaid, The AIDS Drug Assistance Program)¤¬Ç§¤á¤é¤ì¤Æ¤¤¤Þ¤¹¡£¿ô¤¢¤ë¥¢¥á¥ê¥«¤Î¥µ¥×¥ê¥á¥ó¥È²ñ¼Ò¤ÎÃæ¤Ç¤âºÇ¾åµé¤Î¥¯¥ª¥ê¥Æ¥£¡¼¤òÌܻؤ¹OrthoMolecular Products¼Ò¡¢¸¦µæ¤Ë¸¦µæ¤ò½Å¤Í¡¢¡Ö¸ú²Ì¤ò½Ð¤¹¥µ¥×¥ê¥á¥ó¥È¡×¤ò·Ç¤²¤ë¡£¸¶ÎÁ¤Ë¤³¤À¤ï¤êÀ¤³¦¤Î¸¶ÎÁ¥á¡¼¥«¡¼¤«¤éºÇ¹âµé¤Î¸¶ÎÁ¤Î¤ß¤ò»È¤¤¡¢Â¿¤¯¤Î°å»Õ¤«¤é¤Î¿®Íê¤òÆÀ¤Æ¤¤¤ë²ñ¼Ò¤Ç¤¹¡£

¥ß¥È¥³¥¢¡¼¤Î¤ª¾¤¤·¾å¤¬¤êÊý¤ÎÌܰÂ

£±Æü£´¾û¤ò¤ª¾¤¤·¾å¤¬¤ê¤¯¤À¤µ¤¤¡£

¥ß¥È¥³¥¢¡¼¤ÎÆâÍÆÀ®Ê¬

£´¥«¥×¥»¥ëÃæ¡§
¥Ó¥¿¥ß¥ó A ¡ÊÅ·Á³¥«¥í¥Æ¥Î¥¤¥É¡Ë5,000 IU
¥Ó¥¿¥ß¥ó C 250 mg
¥Ó¥¿¥ß¥ó D3 1000 IU
¥Ó¥¿¥ß¥óB1 15 mg
¥Ó¥¿¥ß¥óB2 (Vitamin B2 USP) 15 mg
¥Ê¥¤¥¢¥·¥ó 15 mg
¥Ó¥¿¥ß¥óB6 15 mg
ÍÕ»À ( (6S)-5-¥á¥Á¥ë¥Æ¥È¥é¥Ò¥É¥íÍÕ»À±ö¡Ë 800 mcg
¥Ó¥¿¥ß¥óB12 250 mcg
¥Ó¥ª¥Á¥ó 50 mcg
¥Ó¥¿¥ß¥óB5 (d-¥«¥ë¥·¥¦¥à¥Ñ¥ó¥È¥Æ¥ó»À±ö) 15 mg
¥«¥ë¥·¥¦¥à 75 mg
¥è¡¼¥É 37 mcg
¥Þ¥°¥Í¥·¥¦¥à (Di-¥Þ¥°¥Í¥·¥¦¥à¥ê¥ó¥´»À±ö) 75 mg
°¡±ô (°¡±ô¥°¥ê¥·¥Í¡¼¥È¥­¥ì¡¼¥È) 5 mg
¥»¥ì¥ó (¥»¥ì¥ó¥°¥ê¥·¥Í¡¼¥ÈÊ£¹çÂÎ) 75 mcg
¥Þ¥ó¥¬¥ó (¥Þ¥ó¥¬¥ó¥°¥ê¥·¥Í¡¼¥È¥­¥ì¡¼¥È) 1 mg
¥¯¥í¥à 50 mcg
¥«¥ê¥¦¥à 30 mg
N¡Ý¥¢¥»¥Á¥ë¥·¥¹¥Æ¥¤¥ó USP 600 mg
¥¢¥»¥Á¥ë L-¥«¥ë¥Ë¥Á¥ó HCl 500 mg
¥ê¥ó¥´»À 215 mg
¥¢¥ë¥Õ¥¡¥ê¥Ý»À 200 mg
¥È¥³¥Õ¥§¥í¡¼¥ë 50 mg
ÎÐÃãÃê½Ðʪ ( 45% EGCG) 45 mg
¥Ö¥í¥Ã¥³¥ê¡¼¼ï»ÒÃê½Ðʪ (13% ¥¹¥ë¥Õ¥©¥é¥Õ¥¡¥ó) 40 mg
¥³¥ê¥ó 15 mg
¥¤¥Î¥·¥È¡¼¥ë 15 mg
¥ì¥¹¥Ù¥é¥È¥í¡¼¥ë¡Ê¥È¥é¥ó¥¹¡Ë 10 mg

»²¾È

J Acquir Immune Defic Syndr 2006;42(5): 523-528., Proc Natl Acad Sci U S A. 1994; 91(23):10771-10778., Proc Natl Acad Sci U S A. 2002; 99(4):1870-1875., Clin Immunol 1999; 92(1):103-110., J Clin Chem Clin Biochem 1990; 28(5):307-311., Altern Med Rev 2000; 5(4):290-305., Altern Med Rev 2006; 11(3):232-237., Mech Ageing Dev 2010;131(7-8):473-479., Ann N Y Acad Sci 2004;1033:108-116., Altern Med Review 2010; 15(12):152-158., Food Chem Tox 1999:37:973-979., Altern Med Review 2000; 5(4):372-5

¤³¤Î¾¦ÉʤòÇã¤Ã¤¿¿Í¤Ï¤³¤ó¤Ê¾¦ÉʤâÇã¤Ã¤Æ¤¤¤Þ¤¹

¤³¤Î¾¦ÉʤΥì¥Ó¥å¡¼

  • ¤È¤é¤ó¤×
  • 40Âå
  • ÃËÀ­
¹Ã¾õÁ£µ¡Ç½Äã²¼¾É¤Ç¿É¤¯¡¢¶ì¤·¤¤¤Ç¤¹¡£¤Ç¤â¤³¤Î¥µ¥×¥ê¤ò°û¤à¤È¡¢ÈèÏ«´¶¤Èµ¤Ê¬¤ÎÉ⤭ÄÀ¤ß¤¬Íî¤ÁÃ夭½õ¤«¤Ã¤Æ¤¤¤Þ¤¹¡£

¤³¤Î¾¦ÉʤΥì¥Ó¥å¡¼

  • ¶Ñ
  • 40Âå
  • ÃËÀ­
ËýÀ­¤Î¥é¥¤¥àÉ¤Τ¿¤á¡¢¤¿¤¯¤µ¤ó¤Î¥µ¥×¥ê¥á¥ó¥È¤ò»î¤·Â³¤±¤Æ¤­¤Þ¤·¤¿¡£¥ß¥È¥³¥¢¡¼¤Ï¡¢º£¤Þ¤Ç¤Î¥µ¥×¥ê¥á¥ó¥È¤ÎÃæ¤Ç°ìÈÖ¡¢ÈèÏ«¸ú²Ì¤¬ºÇ¹â¤Ç¤·¤¿¡£

¤³¤Î¾¦ÉʤΥì¥Ó¥å¡¼

  • ¥Þ¡¼¥È
  • 40Âå
  • ÃËÀ­
£²Ç¯¤Û¤ÉÉþÍѤ·¤Æ¤¤¤ë¤Î¤Ç¤¹¤¬¡¢¸ú²Ì¤Ï¤¹¤´¤¤¤Ç¤¹¡£Ìȱ֥·¥¹¥Æ¥à¤Î²þÁ±¤À¤±¤Ç¤Ï¤Ê¤¯¡¢Â¿¤¯¤Î¾É¾õ¤ò²þÁ±¤·¤Æ¤¯¤ì¤Þ¤·¤¿¡£¤½¤ì°Ê¹ßɵ¤¤Ë¤Ê¤é¤Ê¤¯¤Ê¤ë¤Û¤É¤Ç¤¹¡£¤¢¤ê¤¬¤È¤¦¤´¤¶¤¤¤Þ¤·¤¿¡£

¤³¤Î¾¦ÉʤΥì¥Ó¥å¡¼

  • ¥Õ¥ë¥Ü¥Ç¥£
  • 30Âå
  • ÃËÀ­
¥Þ¥°¥Í¥·¥¦¥à¥°¥ê¥·¥Í¡¼¥È¤È°ì½ï¤Ë¥ß¥È¥³¥¢¡¼¤ò£±Æü£²²óÀݤ俤顢­¤ÎáÛÚ»¤¬¾Ã¤¨¤Þ¤·¤¿¡ª¡ª

¤³¤Î¾¦ÉʤΥì¥Ó¥å¡¼

  • ¤·¤ã¤Ö¤·¤ã¤Ö
  • 50Âå
  • ½÷À­
¼ç¿Í¤¬ÀݤäƤ¤¤ë¤Î¤Ç¤¹¤¬¡¢Àݤë¤ÈÊ̿ͤΤ褦¤Ç¤¹¡£¤È¤Æ¤â¶¯ÎϤʥӥ¿¥ß¥ó¤Ê¤Î¤Ç¤·¤ç¤¦¤Í¡££±Æü¤ÎÌܰ¤¬£´¾û¤È¤Ê¤Ã¤Æ¤¤¤Þ¤¹¤¬¡¢£²²ó¤·¤«ÀݤäƤ¤¤Ê¤¯¤Æ¤â¸ú²ÌÂç¤Î¤è¤¦¤Ç¤¹¡£

¥Ô¥Ã¥¯¥¢¥Ã¥×

¤´ÍøÍÑ¥¬¥¤¥É

¤ª»Ùʧ¤¤ÊýË¡

¤ª»Ùʧ¤¤ÊýË¡

  • ÇÛÁ÷ÊýË¡¤Ë¥á¡¼¥ë¥×¥é¥¹¤ò¤´ÁªÂò¤Î¾ì¹ç¡¢¤´Ãíʸ¶â³Û¤Ë¤è¤ê´ØÀǤ¬É¬ÍפȤʤë¾ì¹ç¤¬¤´¤¶¤¤¤Þ¤¹¡£
    ¤½¤ÎºÝ¤Ë¤ÏÃíʸÆâÍÆ¤ò³Îǧ¸å¡¢e¥á¡¼¥ë¤Ç¤ªµÒÍͤËľÀܤªÃΤ餻¤¤¤¿¤·¤Þ¤¹¡£
    ¾Ü¤·¤¯¤ÏÇÛÁ÷¤Ë¤Ä¤¤¤Æ¤Î¥Ú¡¼¥¸¤ò¤´³Îǧ¤¯¤À¤µ¤¤¡£
  • ¥¯¥ì¥¸¥Ã¥È¥«¡¼¥É·èºÑ¤ò¤´´õ˾¤Î¤ªµÒÍͤÏPayPal¤ò¤´ÍøÍѤ¯¤À¤µ¤¤¡£
    ¾Ü¤·¤¯¤Ï¤ª»Ùʧ¤¤ÊýË¡¤Î¥Ú¡¼¥¸¤ò¤´³Îǧ¤¯¤À¤µ¤¤¡£

ÇÛÁ÷ÊýË¡¡¦Á÷ÎÁ¤Ë¤Ä¤¤¤Æ

ÇÛÁ÷ÊýË¡¤Ï£²¤Ä¤Î¥¿¥¤¥×¤«¤é¤´ÁªÂò¤¤¤¿¤À¤±¤Þ¤¹¡£

  • ¥á¡¼¥ë¥×¥é¥¹¡§¡¡ÆüḀ̈᡼¥ë¥×¥é¥¹¡Ê¤æ¤¦¤Ñ¤Ã¤¯¡Ë¤Ç¤ªÆÏ¤±¤¤¤¿¤·¤Þ¤¹¡£
    ÆüÄÌÂå°ú¤­¡§¡¡¤ª²Ùʪ¤ò¤ª¼õ¤±¼è¤ê¤ÎºÝ¤ËÂå¶â¤ò¤ª»Ùʧ¤¤¤¤¤¿¤À¤±¤Þ¤¹¡£
    ¢¨¤½¤ì¤¾¤ìÇÛÁ÷ÊýË¡¤Ë¤è¤êÆÃħ¤¬°Û¤Ê¤ê¤Þ¤¹¤Î¤Ç¾Ü¤·¤¯¤ÏÇÛÁ÷ÊýË¡¤Î¥Ú¡¼¥¸¤ò¤´³Îǧ¤¯¤À¤µ¤¤¡£

¤´»ÈÍѤÎÌܰ¤ˤĤ¤¤Æ

  • ¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤Ï¡¢¤É¤ó¤Êɵ¤¤Î¿ÇÃÇ¡¢¼£ÎÅ¡¢²þÁ±¡¢¤Þ¤¿¤ÏͽËɤ¹¤ë¤³¤È¤ò°Õ¿Þ¤·¤Æ¤¤¤Þ¤»¤ó¡£¤Þ¤¿¡¢¤´¹ØÆþ¤Î¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤Ï°å»Õ¤¬¸Ä¿Í¤Ë¹ç¤ï¤»¤Æ½èÊý¤¹¤ë¤â¤Î¤È¤Ï°Û¤Ê¤ê¤Þ¤¹¡£ÁªÂò¡¢¤´»ÈÍѤÏÁ´¤Æ¤´¼«¿È¤ÎÀÕǤ¤È¤Ê¤ê¤Þ¤¹¤³¤È¤òͽ¤á¤´Î»¾µ¤¯¤À¤µ¤¤¡£
  • °å»Õ¤Ë¤è¤ë¼£ÎÅ¡¦ÅêÌô¤ò¼õ¤±¤Æ¤¤¤ë¾ì¹ç¤Ï°åÌôÉʤȤÎÁê¸ßºîÍѤβÄǽÀ­¤¬À¸¤¸¤ë²ÄǽÀ­¤¬¤¢¤ê¤Þ¤¹¤Î¤Ç¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤Î»ÈÍѤˤĤ¤¤Æ¤ÏôÅö°å»Õ¤Î»ØÆ³¤ò¼õ¤±¤Æ²¼¤µ¤¤¡£ÆÃ¤Ë°å»Õ¤ÎȽÃǤò·Ð¤º¤Ë¼£ÎÅ¡¦°åÌôÉʤλÈÍѤòÃæÃǤ·¡¢¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤ò»ÈÍѤ¹¤ë¤è¤¦¤Ê¹Ô°Ù¤Ï ¡ÈÀäÂÐ¤Ë¡É ¤ª¤ä¤á²¼¤µ¤¤¡£
  • ¥á¡¼¥«¡¼¤Î¼¨¤¹ÍÑË¡ÍÑÎ̤ò¼é¤Ã¤Æ¤´»ÈÍѤ¯¤À¤µ¤¤¡£
  • »ÈÍѼԤÎÂÎÄ´¡¢ÂμÁ¤Ë¤è¤Ã¤Æ¤Ï¿ÈÂΤ˹ç¤ï¤Ê¤¤¤³¤È¤¬¤¢¤ê¤Þ¤¹¡£ÉÔ²÷¤ò´¶¤¸¤¿¾ì¹ç¤Ï°ÂÁ´¤Î¤¿¤áľ¤Á¤Ë¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤Î»ÈÍѤòÃæ»ß¤·¤Æ²¼¤µ¤¤¡£
  • ¸Ä¿ÍÍ¢Æþ¤Ç°ìÅÙ¤ËÍ¢Æþ¤Ç¤­¤ë¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤Î¿ôÎ̤ˤÏÀ©¸Â¤¬¤¢¤ê¤Þ¤¹¡£ÂçÎ̤ˤ´¹ØÆþ¤Ë¤Ê¤é¤º¡¢µ¬À©¤ÎÈÏ°ÏÆâ¤ÇɬÍ×ʬ¤Î¤ß¤ò¤´¹ØÆþ²¼¤µ¤¤¡£
  • ¸Ä¿ÍÍ¢Æþ¤Ç»ý¤Á¹þ¤Þ¤ì¤¿¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤Ï¡¢¼«¸ÊÀÕǤ¤Ë¤è¤ë¡Ö¸Ä¿Í»ÈÍѡפΤߤ¬µö²Ä¤µ¤ì¤Æ¤ª¤ê¤Þ¤¹¡£¤Ç¤¹¤Î¤ÇË¡¿Í¡¦ÃÄÂÎ̾µÁ¤Ç¤Î¤´Ãíʸ¤Ï¤ª¼õ¤±¤¹¤ë¤³¤È¤Ï¤Ç¤­¤Þ¤»¤ó¡£¤Þ¤¿¡¢¸Ä¿ÍÍ¢Æþ¤·¤¿¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤ò¾¿Í¤Ø¤Î¾ùÅÏ¡¦Å¾Ç䤹¤ë¤³¤È¤Ïǧ¤á¤é¤ì¤Æ¤ª¤ê¤Þ¤»¤ó¡£
  • ¢¨¥É¥¯¥¿¡¼¥µ¥×¥êUSA¤Ï¥¢¥á¥ê¥« ¥«¥ê¥Õ¥©¥ë¥Ë¥¢½£¤Î¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥ÈÈÎÇä¶È¼Ô¤Ç¤¹¡£¥¢¥á¥ê¥« ¥«¥ê¥Õ¥©¥ë¥Ë¥¢½£¤ÎË¡µ¬¤Ë½¾¤Ã¤¿É½µ­¡¢ÈÎÇä¤ò¹Ô¤Ã¤Æ¤ª¤ê¤Þ¤¹¡£

¡ú¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤ÎÀâÌÀ¤Ë´Ø¤·¤Æ¤Ï¡¢¤¢¤¯¤Þ¤Ç°ìÈÌŪ¤Ê¾É¾õ¤ËÂФ·¤ÆÍ­¸ú¤Ç¤¢¤ë¤È¤¤¤¦¤â¤Î¤Ç¤¢¤ê¡¢Dr.Ozawa¤¬¸Ä¿Í¤ËÂФ·¤ÆÄ¾ÀÜ¥¢¥É¥Ð¥¤¥¹¤·¤¿¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£¤É¤¦¤¾¤´Íý²ò¤Î¾å¡¢¤´¹ØÆþ¤ò¤ª´ê¤¤¤¤¤¿¤·¤Þ¤¹¡£

Dr.Ozawa HP ¢ª http://www.ozawand.com/


¥¯¥ê¥Ë¥Ã¥¯HP
¥¯¥ê¥Ë¥Ã¥¯HP

ºÇ¿·¤Î¼«Á³ÎÅË¡¡¢
±ÉÍܾðÊó¤ò¿ï»þ¹¹¿·¤·¤Æ¤¤¤Þ¤¹¡£

¤ªµÒÍͤؤΥá¥Ã¥»¡¼¥¸

¡ÈËÜʪ¤Î¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¡É
¤Î¤ß¤ªÆÏ¤±¤·¤Þ¤¹¡£

¥É¥¯¥¿¡¼¥µ¥×¥êUSA¤Ç¤Ï¡¢»ä¤Î¥¯¥ê¥Ë¥Ã¥¯¤Ç¸ú²Ì¤¬¤¢¤Ã¤¿¡Ö¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¡×¤À¤±¤ò¥»¥ì¥¯¥È¤·¤Æ¤´¾Ò²ð¤·¤Æ¤¤¤Þ¤¹¡£Í½Ëɰ峨¡¢¥µ¥×¥ê¥á¥ó¥È¼£ÎŤÎÀè¿Ê¹ñ¥¢¥á¥ê¥«¤ÇÀ¸¤Þ¤ì¤¿¡Ö¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¡×¤Ç¤¹¤¬¡¢ÆüËܤǤϻÄǰ¤Ê¤³¤È¤Ë¤Þ¤À¤¢¤Þ¤ê¿»Æ©¤·¤Æ¤Ï¤¤¤Þ¤»¤ó¡£¥¢¥á¥ê¥«¤Ç¼«Á³ÎÅË¡¤Î¤Ò¤È¤Ä¤È¤·¤ÆÀ®²Ì¤ò¾å¤²¤Æ¤¤¤ë¡Ö¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¡×¤ò¤¼¤Ò¤³¤Îµ¡²ñ¤ËÃΤäƤ¤¤¿¤À¤­¡¢ÂΤÎÉÔÄ´¤ä¤ªº¤¤ê¤Î¾É¾õ¤Î²þÁ±¡¢·ò¹¯°Ý»ý¤ËÌòΩ¤Æ¤Æ¤¤¤¿¤À¤¯¤³¤È¤ò´ê¤Ã¤Æ¤ª¤ê¤Þ¤¹¡£

Dr.Eiji Ozawa ND

¥×¥í¥Õ¥£¡¼¥ë

¼«Á³ÎÅË¡°å²ÊÂç³Ø¤ÇÁ´Êưì¤È¤¤¤ï¤ì¤ë Bastyr University ¤ò´¶È¸å¡¢°å»ÕÌȵö¤ò¼èÆÀ¡£¼«Á³ÎÅË¡°å»Õ¤È¤·¤Æ¥í¥µ¥ó¥¼¥ë¥¹¤Ç10ǯ°Ê¾å¡¢À¾ÍÎ°å³Ø¤ËÊѤï¤ëÁí¹çŪ¼£ÎŤËÎϤòÆþ¤ì¤Æ¤¤¤ë¡£
¥×¥í¥Õ¥£¡¼¥ë¤ò¤â¤Ã¤È¾Ü¤·¤¯



¥â¥Ð¥¤¥ë QR ¥³¡¼¥É

QR¥³¡¼¥É

¥á¥ë¥Þ¥¬¤Î¤´°ÆÆâ¡¡ÅÐÏ¿¡¦²ò½ü¤Ï¤³¤Á¤é
  • RSS1.0
  • ATOM0.3